Related Experiment Video
Updated: Jul 1, 2026

04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Topical hemostatic agents in surgery: a surgeon's perspective.
1Cedars-Sinai Medical Center, Los Angeles, CA, USA.
AORN Journal
|September 16, 2008
Summary
Achieving good surgical hemostasis offers significant benefits. Active hemostatic agents, which participate in the coagulation cascade, are ideal for managing minor bleeding during surgery.
Area of Science:
- Surgical hemostasis
- Hemostatic agents
- Coagulation cascade
Background:
- Effective hemostasis in surgery benefits patients, surgical teams, and healthcare facilities.
- Active and passive hemostatic agents have a long history of safe and effective use across various surgical procedures.
Purpose of the Study:
- To review the role and selection criteria for topical hemostatic agents in surgical procedures.
- To highlight the advantages of active hemostatic agents in managing surgical bleeding.
Main Methods:
- Literature review on hemostatic agents used in surgery.
- Analysis of factors influencing the choice of hemostatic agents.
- Evaluation of the mechanism of action of active hemostatic agents.
Main Results:
- The choice of hemostatic agent depends on surgical procedure type, bleeding characteristics, agent availability, and patient factors.
- Active hemostatic agents actively participate in the coagulation cascade, making them effective for oozing blood and minor bleeding.
- Active agents can be used independently or in conjunction with passive agents.
Conclusions:
- Optimal use of hemostatic agents requires surgeon familiarity with product preparation and application.
- Active hemostatic agents offer advantages in managing specific types of surgical bleeding.
- Proper selection and application of hemostatic agents are crucial for successful surgical outcomes.
Related Concept Videos
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
